See more : Mrs. Bectors Food Specialities Limited (BECTORFOOD.NS) Income Statement Analysis – Financial Results
Complete financial analysis of McKesson Corporation (MCK) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of McKesson Corporation, a leading company in the Medical – Distribution industry within the Healthcare sector.
You may be interested
- Simris Alg AB (publ) (SIMRIS-B.ST) Income Statement Analysis – Financial Results
- Al Rajhi Banking and Investment Corporation (1120.SR) Income Statement Analysis – Financial Results
- Zhejiang Yankon Group Co., Ltd. (600261.SS) Income Statement Analysis – Financial Results
- Primetech S.A. (PTH.WA) Income Statement Analysis – Financial Results
- CanadaBis Capital Inc. (CANB.V) Income Statement Analysis – Financial Results
McKesson Corporation (MCK)
About McKesson Corporation
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The International segment offers distribution and services to wholesale, institutional, and retail customers in 13 European countries and Canada. The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers. The RxTS segment serves biopharma and life sciences partners and patients to address medication challenges for patients throughout their journeys; connects pharmacies, providers, payers, and biopharma companies to deliver innovative access and adherence solutions; and provides third-party logistics and wholesale distribution support solutions. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 308.95B | 276.71B | 263.97B | 238.23B | 231.05B | 214.32B | 208.36B | 198.53B | 190.88B | 179.05B | 137.61B | 122.46B | 122.73B | 112.08B | 108.70B | 106.63B | 101.70B | 92.98B | 88.05B | 80.51B | 69.51B | 57.12B | 50.01B | 42.01B | 36.73B | 30.38B | 20.86B | 12.89B | 13.72B | 13.19B |
| Cost of Revenue | 296.37B | 264.35B | 250.84B | 226.08B | 219.03B | 202.57B | 197.17B | 187.26B | 179.47B | 167.63B | 129.30B | 115.47B | 116.17B | 106.11B | 103.03B | 101.25B | 96.69B | 88.65B | 84.19B | 77.05B | 66.26B | 54.02B | 47.21B | 39.58B | 34.21B | 27.52B | 19.25B | 11.78B | 12.50B | 12.03B |
| Gross Profit | 12.58B | 12.36B | 13.13B | 12.15B | 12.02B | 11.75B | 11.18B | 11.27B | 11.42B | 11.41B | 8.31B | 6.98B | 6.57B | 5.97B | 5.68B | 5.38B | 5.01B | 4.33B | 3.86B | 3.46B | 3.25B | 3.10B | 2.80B | 2.43B | 2.52B | 2.86B | 1.61B | 1.11B | 1.22B | 1.16B |
| Gross Profit Ratio | 4.07% | 4.47% | 4.97% | 5.10% | 5.20% | 5.48% | 5.37% | 5.68% | 5.98% | 6.37% | 6.04% | 5.70% | 5.35% | 5.33% | 5.22% | 5.04% | 4.93% | 4.66% | 4.39% | 4.30% | 4.67% | 5.43% | 5.59% | 5.79% | 6.87% | 9.43% | 7.71% | 8.61% | 8.88% | 8.82% |
| Research & Development | 179.00M | 89.00M | 70.00M | 74.00M | 96.00M | 71.00M | 125.00M | 341.00M | 392.00M | 392.00M | 456.00M | 480.00M | 440.00M | 407.00M | 376.00M | 364.00M | 347.00M | 284.00M | 223.00M | 182.00M | 172.70M | 149.40M | 135.10M | 147.50M | 112.60M | 114.70M | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 6.91B | 15.55B | 21.07B | 17.70B | 18.34B | 8.40B | 8.14B | 7.47B | 7.28B | 7.90B | 5.42B | 2.35B | 3.07B | 2.76B | 2.57B | 3.08B | 3.19B | 2.79B | 2.48B | 2.27B | 2.09B | 2.02B | 1.95B | 2.08B | 2.05B | 2.22B | 1.16B | 944.50M | 872.90M | 1.12B |
| Selling & Marketing | 1.10B | -7.78B | -10.54B | -8.85B | -9.17B | -8.40B | -8.14B | -7.47B | -7.28B | -7.90B | -5.42B | 1.85B | 764.00M | 767.00M | 746.00M | 743.00M | 744.00M | 673.00M | 611.00M | 550.10M | 513.10M | 499.00M | 427.10M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 8.20B | 7.78B | 10.54B | 8.85B | 9.17B | 8.40B | 8.14B | 7.80B | 7.67B | 8.29B | 5.87B | 4.20B | 149.00M | 3.94B | 3.31B | 3.82B | 3.19B | 2.79B | 2.48B | 2.27B | 2.09B | 2.02B | 1.95B | 2.08B | 2.05B | 2.22B | 1.16B | 944.50M | 872.90M | 1.12B |
| Other Expenses | 298.00M | 497.00M | 259.00M | 223.00M | 12.00M | 182.00M | 130.00M | 90.00M | 58.00M | 63.00M | 32.00M | 10.00M | 3.21B | 2.98B | -20.00M | 3.08B | -5.00M | -6.00M | 45.00M | 1.20B | 0.00 | 0.00 | 22.00M | 111.60M | 201.30M | 199.30M | 87.20M | 71.80M | 71.30M | 69.80M |
| Operating Expenses | 8.68B | 7.78B | 10.54B | 8.85B | 9.26B | 8.47B | 8.26B | 7.80B | 7.67B | 8.29B | 5.87B | 4.68B | 4.42B | 3.94B | 3.67B | 4.18B | 3.53B | 3.07B | 2.75B | 3.66B | 2.26B | 2.17B | 2.10B | 2.33B | 2.37B | 2.53B | 1.25B | 1.02B | 944.20M | 1.19B |
| Cost & Expenses | 305.04B | 272.13B | 261.37B | 234.93B | 228.29B | 211.04B | 205.44B | 195.06B | 187.14B | 175.93B | 135.17B | 120.15B | 120.59B | 110.05B | 106.69B | 105.44B | 100.23B | 91.71B | 86.94B | 80.71B | 68.52B | 56.19B | 49.31B | 41.91B | 36.58B | 30.05B | 20.50B | 12.79B | 13.44B | 13.22B |
| Interest Income | 118.00M | 107.00M | 10.00M | 12.00M | 49.00M | 39.00M | 48.00M | 29.00M | 18.00M | 20.00M | 23.00M | 22.00M | 19.00M | 18.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 252.00M | 248.00M | 178.00M | 217.00M | 249.00M | 264.00M | 283.00M | 308.00M | 353.00M | 374.00M | 303.00M | 240.00M | 251.00M | 222.00M | 187.00M | 144.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 635.00M | 857.00M | 1.00B | 1.22B | 922.00M | 949.00M | 951.00M | 910.00M | 885.00M | 1.02B | 704.00M | 591.00M | 551.00M | 496.00M | 474.00M | 441.00M | 371.00M | 295.00M | 266.00M | 250.90M | 232.10M | 203.70M | 207.50M | 246.10M | 201.30M | 199.30M | 87.20M | 71.80M | 71.30M | 69.80M |
| EBITDA | 4.67B | 5.74B | 3.11B | -3.60B | 2.32B | 4.06B | 3.86B | 4.39B | 4.56B | 4.14B | 3.06B | 2.74B | 2.72B | 2.33B | 2.53B | 1.65B | 1.85B | 1.56B | 1.39B | 29.00M | 1.21B | 929.90M | 905.00M | 450.30M | 332.10M | 531.50M | 449.40M | 164.60M | 345.40M | 50.10M |
| EBITDA Ratio | 1.51% | 2.06% | 1.37% | 1.85% | 1.12% | 1.97% | 1.80% | 2.25% | 2.46% | 2.34% | 2.30% | 2.39% | 2.20% | 2.26% | 2.28% | 1.54% | 1.80% | 1.66% | 1.46% | 1.48% | 1.68% | 1.90% | 1.79% | 1.01% | 0.25% | 1.75% | 2.15% | 1.28% | 2.52% | 0.26% |
| Operating Income | 3.91B | 4.38B | 2.85B | 3.52B | 1.66B | 886.00M | 762.00M | 7.11B | 3.55B | 2.97B | 2.37B | 2.32B | 2.15B | 1.82B | 2.01B | 1.20B | 1.48B | 1.26B | 1.11B | -190.50M | 983.40M | 929.90M | 693.60M | 96.40M | 158.20M | 332.20M | 362.20M | 92.80M | 274.10M | -30.10M |
| Operating Income Ratio | 1.27% | 1.58% | 1.08% | 1.48% | 0.72% | 0.41% | 0.37% | 3.58% | 1.86% | 1.66% | 1.72% | 1.89% | 1.75% | 1.62% | 1.85% | 1.12% | 1.45% | 1.36% | 1.27% | -0.24% | 1.41% | 1.63% | 1.39% | 0.23% | 0.43% | 1.09% | 1.74% | 0.72% | 2.00% | -0.23% |
| Total Other Income/Expenses | -120.00M | 249.00M | -110.00M | 6.00M | -1.35B | -276.00M | -523.00M | -231.00M | -295.00M | -311.00M | -343.00M | -396.00M | -230.00M | -186.00M | -144.00M | -132.00M | -21.00M | 33.00M | 44.00M | -54.50M | -72.00M | -74.50M | -87.50M | -196.30M | 148.70M | -130.20M | -109.40M | -61.70M | -44.40M | -23.40M |
| Income Before Tax | 3.79B | 4.63B | 1.93B | -5.03B | 1.14B | 610.00M | 239.00M | 6.89B | 3.25B | 2.66B | 2.10B | 1.92B | 1.92B | 1.64B | 1.86B | 1.06B | 1.46B | 1.30B | 1.16B | -239.80M | 911.40M | 855.40M | 601.20M | 9.60M | 306.90M | 202.00M | 253.50M | 36.40M | 224.10M | -81.70M |
| Income Before Tax Ratio | 1.23% | 1.67% | 0.73% | -2.11% | 0.50% | 0.28% | 0.11% | 3.47% | 1.70% | 1.48% | 1.52% | 1.57% | 1.56% | 1.46% | 1.71% | 1.00% | 1.43% | 1.39% | 1.32% | -0.30% | 1.31% | 1.50% | 1.20% | 0.02% | 0.84% | 0.66% | 1.22% | 0.28% | 1.63% | -0.62% |
| Income Tax Expense | 629.00M | 905.00M | 636.00M | -695.00M | 18.00M | 356.00M | -53.00M | 1.61B | 908.00M | 815.00M | 742.00M | 581.00M | 516.00M | 505.00M | 601.00M | 241.00M | 468.00M | 329.00M | 421.00M | -83.10M | 264.90M | 293.30M | 182.60M | 52.30M | 122.30M | 117.10M | 98.60M | 31.30M | 88.70M | 111.50M |
| Net Income | 3.00B | 3.56B | 1.11B | -4.34B | 900.00M | 34.00M | 67.00M | 5.07B | 2.26B | 1.48B | 1.26B | 1.34B | 1.40B | 1.20B | 1.26B | 823.00M | 990.00M | 913.00M | 751.00M | -156.70M | 646.50M | 555.40M | 418.60M | -48.30M | 723.70M | 84.90M | 154.90M | 133.90M | 135.40M | 404.50M |
| Net Income Ratio | 0.97% | 1.29% | 0.42% | -1.82% | 0.39% | 0.02% | 0.03% | 2.55% | 1.18% | 0.82% | 0.92% | 1.09% | 1.14% | 1.07% | 1.16% | 0.77% | 0.97% | 0.98% | 0.85% | -0.19% | 0.93% | 0.97% | 0.84% | -0.11% | 1.97% | 0.28% | 0.74% | 1.04% | 0.99% | 3.07% |
| EPS | 22.54 | 25.23 | 7.31 | -27.02 | 4.97 | 0.17 | 0.32 | 22.95 | 9.82 | 6.37 | 5.51 | 5.71 | 5.70 | 4.65 | 4.70 | 2.99 | 3.40 | 3.06 | 2.46 | -0.53 | 2.23 | 1.92 | 1.47 | -0.17 | 2.57 | 0.31 | 1.14 | 0.83 | 1.53 | 4.60 |
| EPS Diluted | 22.39 | 25.04 | 7.23 | -27.02 | 4.95 | 0.17 | 0.32 | 22.73 | 9.70 | 6.27 | 5.41 | 5.59 | 5.59 | 4.57 | 4.62 | 2.95 | 3.32 | 2.99 | 2.38 | -0.53 | 2.19 | 1.88 | 1.43 | -0.17 | 2.55 | 0.31 | 1.10 | 0.80 | 1.45 | 4.43 |
| Weighted Avg Shares Out | 133.20M | 141.10M | 152.30M | 160.60M | 181.00M | 196.30M | 208.00M | 221.00M | 230.00M | 232.00M | 229.00M | 235.00M | 246.00M | 258.00M | 269.00M | 275.00M | 291.00M | 298.00M | 306.00M | 294.00M | 290.00M | 289.30M | 285.20M | 283.10M | 281.30M | 275.20M | 282.10M | 83.65M | 88.50M | 87.93M |
| Weighted Avg Shares Out (Dil) | 134.10M | 142.20M | 154.10M | 160.60M | 182.00M | 197.30M | 209.00M | 223.00M | 233.00M | 235.00M | 233.00M | 239.00M | 251.00M | 263.00M | 273.00M | 279.00M | 298.00M | 305.00M | 316.00M | 294.00M | 299.00M | 298.80M | 298.10M | 283.10M | 284.20M | 275.20M | 282.10M | 84.39M | 93.38M | 91.31M |
McKesson (MCK) Stock Slides as Market Rises: Facts to Know Before You Trade
In the latest trading session, McKesson (MCK) closed at $508.16, marking a -0.68% move from the previous day.
Here's Why You Should Retain McKesson Stock in Your Portfolio Now
MCK's strategic collaborations and strength in Biologics raise optimism about the stock.
Why McKesson (MCK) is a Top Value Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
McKesson - Meet The New Dividend Stock On My Watchlist
McKesson's recent sell-off offers a compelling opportunity, driven by its strong position in healthcare distribution and growing focus on AI and technology for sustainable growth. The company boasts solid revenue and EPS growth, supported by AI integration, expansion into high-demand...
McKesson (MCK) Exceeds Market Returns: Some Facts to Consider
McKesson (MCK) reachead $518.81 at the closing of the latest trading day, reflecting a +1.49% change compared to its last close.
McKesson (MCK) Rises Yet Lags Behind Market: Some Facts Worth Knowing
McKesson (MCK) concluded the recent trading session at $511.17, signifying a +0.14% move from its prior day's close.
McKesson Corporation (MCK) is Attracting Investor Attention: Here is What You Should Know
Zacks.com users have recently been watching McKesson (MCK) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
McKesson, News Corporation And 2 Other Stocks Executives Are Selling
The Nasdaq 100 closed lower by over 500 points during Friday's session. Investors, meanwhile, focused on some notable insider trades.
McKesson Shares Fall Following Sale of Rexall, Well.ca to Birch Hill
MCK announces the sale of its Canada-based Rexall and Well.ca businesses to Birch Hill Equity Partners, aligning with its strategy to grow oncology and biopharma services.
S&P 500 Gains and Losses Today: McKesson Falls Amid Plans To Exit Canada Businesses
Major U.S. equities indexes were mixed as the latest ADP jobs data showed a smaller-than-expected jump in private payrolls in August.
Source: https://incomestatements.info
Category: Stock Reports